These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20100795)

  • 1. Fibromyalgic rheumatoid arthritis and disease assessment.
    Pollard LC; Kingsley GH; Choy EH; Scott DL
    Rheumatology (Oxford); 2010 May; 49(5):924-8. PubMed ID: 20100795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.
    Wolfe F; Michaud K; Pincus T; Furst D; Keystone E
    Arthritis Rheum; 2005 Dec; 52(12):3873-9. PubMed ID: 16320335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia.
    Zammurrad S; Munir W; Farooqi A
    J Coll Physicians Surg Pak; 2013 Jun; 23(6):413-7. PubMed ID: 23763802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
    Wolfe F; Pincus T; O'Dell J
    J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis.
    Westhoff G; Buttgereit F; Gromnica-Ihle E; Zink A
    Rheumatology (Oxford); 2008 Jul; 47(7):980-4. PubMed ID: 18413345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration.
    Pollard LC; Ibrahim F; Choy EH; Scott DL
    J Rheumatol; 2012 Jan; 39(1):28-31. PubMed ID: 22089464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Nov; 31(11):2115-20. PubMed ID: 15517621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis.
    van Hoogmoed D; Fransen J; Bleijenberg G; van Riel P
    Rheumatology (Oxford); 2010 Jul; 49(7):1294-302. PubMed ID: 20353956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
    Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
    J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S; Kvien TK; Uhlig T
    J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia versus disease activity as cause of fatigue in rheumatoid arthritis.
    Escobar ME; Gerhardt C; Roesler E; Kuroda MP; Silva MB; Skare TL
    Acta Reumatol Port; 2010; 35(1):24-8. PubMed ID: 20518145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.
    Durán J; Combe B; Niu J; Rincheval N; Gaujoux-Viala C; Felson DT
    Rheumatology (Oxford); 2015 Dec; 54(12):2166-70. PubMed ID: 26175470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.
    Uhlig T; Kvien TK; Pincus T
    Ann Rheum Dis; 2009 Jun; 68(6):972-5. PubMed ID: 18957489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-driven outcomes in rheumatoid arthritis.
    Wells GA
    J Rheumatol Suppl; 2009 Jun; 82():33-8. PubMed ID: 19509328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DAS28 in rheumatoid arthritis and fibromyalgia patients.
    Leeb BF; Andel I; Sautner J; Nothnagl T; Rintelen B
    Rheumatology (Oxford); 2004 Dec; 43(12):1504-7. PubMed ID: 15252215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.